Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects

• Status: COMPLETED
• Trial end date: 2024-04-15

Summary

This trial is conducted in china. The aim of the trial is as follows:

• To assess the effect of multiple subcutaneous injections of JY09 injection on the pharmacokinetic (PK) profile of multiple oral doses of metformin hydrochloride tablets, a single oral dose of Rosuvastatin calcium tablets, or digoxin tablets in overweight Chinese subjects;
• To assess the effect of multiple subcutaneous injections of JY09 injection on QT interval in overweight Chinese subjects.

• Phase: PHASE1

Details

• Lead Sponsor: Beijing Dongfang Biotech Co., Ltd.
• Treatments: Digoxin; Injections; Metformin; Rosuvastatin Calcium